Samy, director and fellow of green chemistry, helps scientists embrace sustainability in their labs with DOZN, our quantitative green chemistry evaluator. You can try DOZN too! Visit: http://ms.spr.ly/6045mVVPl
Info
Gemeinsam mit unseren Mitarbeitenden, Kunden und Partnerschaften bewirken wir Entscheidendes für Leben und Gesundheit durch Wissenschaft. Bevor Forscher wissenschaftliche Durchbrüche erzielen können, müssen sie Zugang zu modernsten Instrumenten, Dienstleistungen und Fachwissen haben, um Experimente durchzuführen und neue Produkte zu entwickeln. Hier kommen wir ins Spiel. Wir bieten eines der umfangreichsten Portfolios der Branche für Wissenschaftler, erstklassige Produkte für die pharmazeutische Entwicklung und Herstellung sowie eine vollständig integrierte Serviceorganisation zur Unterstützung von CDMO- und Auftragsprüfungen in traditionellen und neuartigen Modalitäten. Unsere Vision ist eine Welt, in der unsere innovativen Produkte, Dienstleistungen und digitalen Angebote dazu beitragen, Lösungen für Menschen auf der ganzen Welt und eine nachhaltige Zukunft für kommende Generationen zu schaffen. Merck ist ein globales Wissenschafts- und Technologieunternehmen mit mehr als 64.000 Mitarbeitern in mehr als 66 Ländern. Nicht für Besucher aus den USA und CA bestimmt.
- Website
-
http://www.sigmaaldrich.com
Externer Link zu Merck Life Science
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Darmstadt
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
Orte
-
Primär
Frankfurter Straße 250
Darmstadt, 64293, DE
Beschäftigte von Merck Life Science
Updates
-
Test your knowledge with this pop quiz. Antibody Drug Conjugates, or ADCs, are revolutionizing how we treat cancer and beyond due to their targeting ability. However, producing them is tricky due to their high potency. Knowing this, can you answer the question below? Learn how the new Mobius ADC reactor can help you produce ADCs faster and safer: http://ms.spr.ly/6046mPdzq
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
Join us on LinkedIn for a live and interactive panel discussion to explore the future of ADCs in cancer treatment. The discussion will focus on recent advancements in technology and integration with other therapies. Key topics will include innovations in antibody engineering, linker chemistry, payload selection, the role of biomarkers, and challenges in manufacturing. This event is an excellent opportunity for experts, researchers, clinicians, and industry professionals to gain insights into the latest developments and future directions of ADCs. Click Attend to RSVP.
Future Directions: Next-GenerationADCs & Combination Therapies
www.linkedin.com
-
This packaging change embodies the phrase "reduce, reuse, and recycle." Rather than using air pillows or purchasing filler paper, our Jigani, India site shreds boxes from incoming shipments, reusing them as filler for boxes shipping off. This saves 14 tons of paper annually. Read about other projects to make our packaging greener here: http://ms.spr.ly/6044mPdz6
-
What if we could tell our bodies to fight off HIV, flu, or cancer? RNA therapeutics have the potential to do just that, but they are fragile and easily broken down in the body before reaching their destination. This is where lipid nanoparticles (LNP), the protective carriers for RNA come in. Scientists like Johanna Simon — along with her colleagues from our Early Formulation Screening Service Team — help clients identify and create customized LNP. By finding the right protective carrier to deliver RNA, their therapeutics are more likely to work. Learn how Johanna and her colleagues can support bringing ideas from discovery to an impactful product for patients here: http://ms.spr.ly/6041mMChH
-
We are thrilled to launch the FIRST single-use reactor specifically designed to manufacture antibody-drug conjugates (ADCs). The new Mobius ADC Reactor enables biopharmaceutical companies to produce their critical therapies faster and safer. ADCs are a groundbreaking technology that targets and selectively kills tumor cells while protecting healthy ones. This new reactor is tailored precisely to meet the unique requirements for ADC manufacturing. By embracing single-use technology, the new Mobius ADC Reactor can boost manufacturing efficiency by 70% compared to traditional methods. Learn more about this innovation here: http://ms.spr.ly/6049mzQZ5
-
Merck Life Science hat dies direkt geteilt
Some of the most important innovations are also the smallest. Meet the Mobius Breez Microbioreactor, one of the smallest automated perfusion microbioreactor ever created. This innovative microbioreactor helps our customers predict optimum cell culture processes before ramping up production at a larger scale. That helps our customers increase efficiency and reduce development timelines, meaning drugs can move through the development process faster and get to patients even more quickly. Our scientists and engineers tirelessly work to develop novel approaches to our customers' biggest challenges. Even when those challenges only require a “small” innovation, our Merck Life Science colleagues find new ways to create impactful solutions.
-
A researcher creates a new test for an old disease. Read her story: http://ms.spr.ly/6041mDT5X Testing for Hansen’s disease—formerly known as Leprosy—used to be confined to specialized clinics. It was difficult to get tested, diagnosed, and treated, especially in remote areas, where hotspots tend to occur. Motivated by the experience of someone close to her, one researcher set out to create a more accessible testing option.
-
Big news! We're the FIRST in the industry to receive EXCiPACT cGMP certification for cell culture manufacturing. This certification highlights our commitment to the safety, quality, and efficacy of cell culture media used in drug components. Cell culture media is an essential raw material used in life-saving therapies and processes as varied as gene therapy, vaccine, and monoclonal antibody manufacturing. Because of its central role in biomanufacturing, a consistent supply of high-quality media is required to deliver the necessary concentration and protein quality for therapeutics. More on this news here: http://ms.spr.ly/6044mBFM2